What Happened?
Shares of telehealth company Hims & Hers Health (NYSE: HIMS) fell 4% in the afternoon session after the stock's momentum weakened as Amazon.com entered the weight management market through its One Medical platform.
The entry of a global giant like Amazon into a key business area for Hims & Hers raised concerns among investors. Amazon's announcement in mid-April to add a weight management service positioned it as a direct competitor.
The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy Hims & Hers Health? Access our full analysis report here, it’s free.
What Is The Market Telling Us
Hims & Hers Health’s shares are extremely volatile and have had 73 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business.
The previous big move we wrote about was 4 days ago when the stock gained 9.6% on the news that JPMorgan initiated coverage on the company with a 'Buy'-equivalent 'Overweight' rating and a $35 price target.
The bank pointed to the company's improving fundamentals and multiple growth drivers as reasons for its positive outlook. Analysts highlighted a key partnership with Novo Nordisk, which they believed marked a turning point for Hims & Hers' weight-loss business. This collaboration specifically targeted the fast-growing market for GLP-1 drugs. JPMorgan's price target suggested a 17% potential upside from where the stock was trading.
Hims & Hers Health is down 15.9% since the beginning of the year, and at $28.08 per share, it is trading 57.6% below its 52-week high of $66.18 from July 2025. Despite the year-to-date decline, investors who bought $1,000 worth of Hims & Hers Health’s shares 5 years ago would now be looking at an investment worth $2,274.
ONE MORE THING: 3 Hidden Platforms Growing 3X Faster than Amazon, Google, and PayPal. Amazon, Google, and Meta all followed the same playbook: Dominate an ignored market. Build an unbeatable moat. Scale until you’re unstoppable.
These three platforms are running that exact playbook right now. The early investors in Amazon made fortunes. The early investors in these could do the same. Get All 3 Stocks Here for FREE.
